AGIO
Agios Pharmaceuticals Inc
NASDAQ · Biotechnology
$26.53
-0.04 (-0.15%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 36.77M | 50.47M | 202.30M | 198.27M | 200.72M |
| Net Income | 678.67M | 838.44M | -11,058,235 | -11,344,752 | -12,565,080 |
| EPS | — | — | — | — | — |
| Profit Margin | 1,845.9% | 1,753.6% | -5.5% | -5.7% | -6.3% |
| Rev Growth | -27.2% | -27.2% | +1.9% | -2.9% | -8.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 269.44M | 267.01M | 273.20M |
| Total Equity | — | — | 1.12B | 1.12B | 1.12B |
| D/E Ratio | — | — | 0.24 | 0.24 | 0.24 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 680.49M | 887.40M | -14,061,341 | -15,767,673 | -13,652,238 |
| Free Cash Flow | — | — | -10,472,931 | -7,306,109 | -10,881,640 |